NEW YORK (GenomeWeb news) – Texas A&M's Institute for Genomic Medicine will receive $3.2 million from the Environmental Protection Agency to conduct genomics research as part of a program that includes the University of Houston and Indiana University and is studying how chemicals may affect human health.

The university said today that it will receive $750,000 over three years from the EPA's Science to Achieve Results Program (STAR), which it will use to be a member of the Texas-Indiana Virtual STAR Center.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.